Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 859-866

  Asanuma, Hideomi ^a,c   Sharp, Margaret ^a   Maecker, Holden T ^b   Maino, Vernon C ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BD Technologies   (United States)

^c Otaru Kyokai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; HELPER CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MEMORY CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; SIMPLEXVIRUS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034116706     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315347     Document Type: Article

References (34)

1. 1. I. Arvin AM. Varicella-zoster virus. In: Fields B, Knipe D, Howley P, eds. Virology. New York: Lippincott-Raven Press, 1995:2547-86.
2. 2. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997;99:1092-7.
3. 3. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-26.
4. 4. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokine by flow cytometry. J Immunol Methods 1993;159: 197-207.
5. 5. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995;188:117-28.
6. + T-cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997;99:1739-50.
7. 7. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998;34:207-15.
8. 8. Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T-cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998;212:89-98.
9. 9. Hayward AR, Herberger M. Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol 1987;7:174-8.
10. + phenotype. J Immunol 1991;146:257-6.
11. 11. Hayward AR, Herberger MJ, Groothuis J, Levin MR. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J Immunol 1984;133:2469-73.
12. 12. Arvin AM, Gershon AA. Live attenuated varicella vaccine. Annu Rev Microbiol 1996;50:59-100.
13. 13. Arvin AM, The immune response to varicella-zoster virus. Infect Dis Clin North Am 1996;10:529-70.
14. 14. Hayward A, Villanueba E, Cosyns M, Levin M. Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine. J Infect Dis 1992;166:260-4.
15. 15. Sharp M, Terada K, Wilson A, et al. Kinetics and viral protein specificity of the cytotoxic T-lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis 1992;165:852-8.
16. 16. Nader S, Bergen R, Sharp M, Arvin AM. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis 1995;171: 13-7.
17. 17. Schmader K. Postherpetic neuralgia in immunocompetent elderly people. Vaccine 1998;16:1768-70.
18. 18. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994;170:522-6.
19. 19. Berger R, Trannoy E, Hollander G, Bailleux F, Rudin C, Creusvaux H. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J Infect Dis 1998;178(Suppl 1):S99-103.
20. 20. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998; 178(Suppl 1):S109-23.
21. + cytotoxic T lymphocytes. J Clin invest 1993;91:961-8.
22. 22. Rock KL. A new foreign policy: MHC class 1 molecules monitor the outside world. Immunol Today 1996;17:131-7.
23. 23. Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992;65:119-38.
24. 24. Meier JL, Straus SE. Comparative biology of latent varicella-zoster virus and herpes simples virus infections. J Infect Dis 1992;166(Suppl 1): S13-23.
25. 25. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
26. 26. Bergen RE, Diaz PS, Arvin AM. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J Infect Dis 1990;162:1049-54.
27. 27. Watson B, Boardman C, Laufer D, et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis 1995;20:316-9.
28. 28. Arvin AM, Koropchak CM, Willias BRG, Grumet FC, Foung KH. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986;154:422-9.
29. 29. Ito M, Nakano T, Kamiya T, et al. Effects of tumor necrosis factor alpha on replication of varicella-zoster virus. Antiviral Res 1991;15:183-92.
30. 30. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and interferon gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998;178:940-8.
31. 31. Yokota S, Geppert TD. Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor alpha. J Immunol 1988;140:531-6.
32. 32. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994;98:128-33.
33. 33. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980;30:582-7.
34. 34. Levin MJ, Hayward AR. Prevention of herpes zoster. Infect Dis Clin North Am 1996;10:657-75.